Publications of Bernd Neumaier

Endepols, H.; Anglada-Huguet, M.; Mandelkow, E.; Schmidt, Y.; Krapf, P.; Zlatopolskiy, B. D.; Neumaier, B.; Drzezga, A.: Assessment of the in vivo relationship between cerebral hypometabolism, Tau deposition, TSPO expression, and synaptic density in a tauopathy mouse model: a multi-tracer PET study. Molecular Neurobiology 59 (6), pp. 3402 - 3413 (2022)

Endepols, H.; Zlatopolskiy, B. D.; Zischler, J.; Alavinejad, N.; Apetz, N.; Vus, S.; Drzezga, A.; Neumaier, B.: Imaging of cerebral tryptophan metabolism using 7-[18F]FTrp-PET in a unilateral Parkinsonian rat model. NeuroImage 247, 118842 (2022)

Richter, N.; David, L.-S.; Grothe, M. J.; Teipel, S.; Dietlein, M.; Tittgemeyer, M.; Neumaier, B.; Fink, G. R.; Onur, O. A.; Kukolja, J.: Age and anterior basal forebrain volume predict the cholinergic deficit in patients with mild cognitive impairment due to Alzheimer's disease. Journal of Alzheimer's Disease: JAD 86 (1), pp. 425 - 440 (2022)

Walter, H. L.; Pikhovych, A.; Endepols, H.; Rotthues, S.; Baermann, J.; Backes, H.; Hoehn, M.; Wiedermann, D.; Neumaier, B.; Fink, G. R. et al.; Rueger, M. A.; Schroeter, M.: Transcranial-Direct-Current-Stimulation accelerates motor recovery after cortical infarction in mice: The interplay of structural cellular responses and functional recovery. Neurorehabilitation and Neural Repair (accepted)

Walter, N.; Bertram, J.; Drewes, B.; Bahutsky, V.; Timmer, M.; Schütz, M. B.; Krämer, F.; Neumaier, F.; Endepols, H.; Neumaier, B. et al.; Zlatopolskiy, B. D.: Convenient PET-tracer production via SuFEx 18F-fluorination of nanomolar precursor amounts. European Journal of Medicinal Chemistry 237, 114383 (2022)

Apetz, N.; Paralikar, K.; Neumaier, B.; Drzezga, A.; Wiedermann, D.; Iyer, R.; Munns, G.; Scott, E.; Timmermann, L.; Endepols, H.: Towards chronic deep brain stimulation in freely moving hemiparkinsonian rats: applicability and functionality of a fully implantable stimulation system. Journal of Neural Engineering 18 (3), 036018 (2021)

Hoffmann, C.; Evcüman, S.; Neumaier, F.; Zlatopolskiy, B. D.; Humpert, S.; Bier, D.; Holschbach, M.; Schulze, A.; Endepols, H.; Neumaier, B.: [F-18]ALX5406: A brain-penetrating prodrug for GlyT1-specific PET imaging. ACS Chemical Neuroscience 12 (18), pp. 3335 - 3346 (2021)

Krämer, F.; Groner, B.; Hoffmann, C.; Craig, A.; Brugger, M.; Drzezga, A.; Timmer, M.; Neumaier, F.; Zlatopolskiy, B. D.; Endepols, H. et al.; Neumaier, B.: Evaluation of 3-l- and 3-d-[18F]Fluorophenylalanines as PET Tracers for Tumor Imaging. Cancers / Molecular Diversity Preservation International (MDPI) 13 (23), 6030 (2021)

Meinhardt, M. W.; Pfarr, S.; Fouquet, G.; Rohleder, C.; Meinhardt, M. L.; Barroso-Flores, J.; Hoffmann, R.; Jeanblanc, J.; Paul, E.; Wagner, K. et al.; Hansson, A. C.; Köhr, G.; Meier, N.; Halbach, O. v. B. u.; Bell, R. L.; Endepols, H.; Neumaier, B.; Schönig, K.; Bartsch, D.; Naassila, M.; Spanagel, R.; Sommer, W. H.: Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Science Advances 7 (47), eabh2399 (2021)

Orlovskaya, V. V.; Craig, A. S.; Fedorova, O. S.; Kuznetsova, O. F.; Neumaier, B.; Krasikova, R. N.; Zlatopolskiy, B. D.: Production of 6-l-[18F]fluoro-m-tyrosine in an automated synthesis module for 11C-labeling. Molecules 26 (18), 5550 (2021)

Craig, A.; Kolks, N.; Urosova, E. A.; Zischler, J.; Brugger, M.; Endepols, H.; Neumaier, B.; Zlatopolskiy, B. D.: Preparation of labeled aromatic amino acids via late-stage 18F-fluorination of chiral nickel and copper complexes. Chemical Communications 56 (66), pp. 9505 - 9508 (2020)

Neumaier, F.; Zlatopolskiy, B. D.; Neumaier, B.: Nuclear medicine in times of COVID-19: How radiopharmaceuticals could help to fight the current and future pandemics. Pharmaceutics 12 (12), 1247 (2020)

Zlatopolskiy, B. D.; Endepols, H.; Krasikova, R. N.; Fedorova, O. S.; Ermert, J.; Neumaier, B.: C-11- and F-18-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders. Russian Chemical Reviews 89 (9), pp. 879 - 896 (2020)

Zlatopolskiy, B. D.; Neumaier, F.; Rüngeler, T.; Drewes, B.; Kolks, N.; Neumaier, B.: Preparation of a first 18F-labeled agonist for M1 muscarinic acetylcholine receptors. Molecules 25 (12), 2880 (2020)

Apetz, N.; Kordys, E.; Simon, M.; Mang, B.; Aswendt, M.; Wiedermann, D.; Neumaier, B.; Drzezga, A.; Timmermann, L.; Endepols, H.: Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model. Disease Models and Mechanisms 12 (5), UNSP dmm039065 (2019)

Modemann, D. J.; Zlatopolskiy, B. D.; Urusova, E. A.; Zischler, J.; Austin, C.; Ermert, J.; Guliyev, M.; Endepols, H.; Neumaier, B.: 2-[ 18 F]Fluorophenylalanine: synthesis by nucleophilic 18 F-fluorination and preliminary biological evaluation. Synthesis 51 (3), pp. 664 - 676 (2019)

Orlovskaya, V. V.; Modemann, D. J.; Kuznetsova, O. F.; Fedorova, O. S.; Urusova, E. A.; Kolks, N.; Neumaier, B.; Krasikova, R. N.; Zlatopolskiy, B. D.: Alcohol-supported Cu-mediated 18F-fluorination of iodonium salts under “minimalist” conditions. Molecules 24 (17), 3197 (2019)

Richter, N.; Nellessen, N.; Dronse, J.; Dillen, K.; Jacobs, H. I.L.; Langen, K.-J.; Dietlein, M.; Kracht, L.; Neumaier, B.; Fink, G. R. et al.; Kukolja, J.; Onur, O. A.: Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD. NeuroImage: Clinical 24, 101978 (2019)

Zlatopolskiy, B. D.; Endepols, H.; Krapf, P.; Guliyev, M.; Urusova, E. A.; Richarz, R.; Hohberg, M.; Dietlein, M.; Drzezga, A.; Neumaier, B.: Discovery of F-18-JK-PSMA-7, a PET probe for the detection of small PSMA-positive lesions. Journal of Nuclear Medicine 60 (6), pp. 817 - 823 (2019)

Zlatopolskiy, B. D.; Zischler, J.; Krapf, P.; Richarz, R.; Lauchner, K.; Neumaier, B.: Minimalist approach meets green chemistry: Synthesis of 18F- labeled (hetero)aromatics in pure ethanol. Journal of Labelled Compounds and Radiopharmaceuticals 62 (8), pp. 404 - 410 (2019)